MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm
Werte in diesem Artikel
NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MEDP.
Investigation DetailsOn October 21, 2024, Medpace reported its third quarter 2024 financial results, which cut its revenue guidance for the full year. During an investor call the next day, the Company described higher cancellations in the third quarter. The Company's net book-to-bill ratio was a low 1.00 for the third quarter, below analyst estimates and historically low compared to its past performance. Following this news, Medpace stock dropped.
What's Next?If you are aware of any facts relating to this investigation or purchased Medpace securities, you can assist this investigation by visiting the firm's site: bgandg.com/MEDP. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to YouWe represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & GrossmanBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
ContactBronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/medp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-an-investigation-into-medpace-holdings-inc-and-encourages-investors-to-contact-the-firm-302289654.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Ausgewählte Hebelprodukte auf Medpace
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Medpace
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Medpace Holdings Inc
Analysen zu Medpace Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
06.09.2016 | Medpace Buy | UBS AG | |
06.09.2016 | Medpace Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
06.09.2016 | Medpace Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
06.09.2016 | Medpace Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Medpace Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen